approaching the crossroads

1.supplementary tests (started Oct 10)Duration said to be 28 days,so must assume that by now they are well and truly completed and that a report to SBP from Qld is in progress or even finished.
Success here is crucial to the progression to phase2 clinical trials.

2.The US patient will be on cycle 4 now and so there is potential for some sort of progress report any time from now on.

The lack of interest by the market may well be the calm before the storm, especially if both sets of tests are positive


DYOR